219 related articles for article (PubMed ID: 36418293)
1. Enhanced activity of Alzheimer disease-associated variant of protein kinase Cα drives cognitive decline in a mouse model.
Lordén G; Wozniak JM; Doré K; Dozier LE; Cates-Gatto C; Patrick GN; Gonzalez DJ; Roberts AJ; Tanzi RE; Newton AC
Nat Commun; 2022 Nov; 13(1):7200. PubMed ID: 36418293
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase Cα gain-of-function variant in Alzheimer's disease displays enhanced catalysis by a mechanism that evades down-regulation.
Callender JA; Yang Y; Lordén G; Stephenson NL; Jones AC; Brognard J; Newton AC
Proc Natl Acad Sci U S A; 2018 Jun; 115(24):E5497-E5505. PubMed ID: 29844158
[TBL] [Abstract][Full Text] [Related]
3. Gain-of-function mutations in protein kinase Cα (PKCα) may promote synaptic defects in Alzheimer's disease.
Alfonso SI; Callender JA; Hooli B; Antal CE; Mullin K; Sherman MA; Lesné SE; Leitges M; Newton AC; Tanzi RE; Malinow R
Sci Signal; 2016 May; 9(427):ra47. PubMed ID: 27165780
[TBL] [Abstract][Full Text] [Related]
4. PKC ε activation prevents synaptic loss, Aβ elevation, and cognitive deficits in Alzheimer's disease transgenic mice.
Hongpaisan J; Sun MK; Alkon DL
J Neurosci; 2011 Jan; 31(2):630-43. PubMed ID: 21228172
[TBL] [Abstract][Full Text] [Related]
5. Neuronal Protein Tyrosine Phosphatase 1B Hastens Amyloid β-Associated Alzheimer's Disease in Mice.
Ricke KM; Cruz SA; Qin Z; Farrokhi K; Sharmin F; Zhang L; Zasloff MA; Stewart AFR; Chen HH
J Neurosci; 2020 Feb; 40(7):1581-1593. PubMed ID: 31915254
[TBL] [Abstract][Full Text] [Related]
6. Protein Kinase C Involvement in Neuroprotective Effects of Thymol and Carvacrol Against Toxicity Induced by Amyloid-β in Rat Hippocampal Neurons.
Azizi Z; Choopani S; Salimi M; Majlessi N; Naghdi N
Basic Clin Neurosci; 2022; 13(3):295-304. PubMed ID: 36457884
[TBL] [Abstract][Full Text] [Related]
7. APP/Go protein Gβγ-complex signaling mediates Aβ degeneration and cognitive impairment in Alzheimer's disease models.
Bignante EA; Ponce NE; Heredia F; Musso J; Krawczyk MC; Millán J; Pigino GF; Inestrosa NC; Boccia MM; Lorenzo A
Neurobiol Aging; 2018 Apr; 64():44-57. PubMed ID: 29331876
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's-specific effects of soluble beta-amyloid on protein kinase C-alpha and -gamma degradation in human fibroblasts.
Favit A; Grimaldi M; Nelson TJ; Alkon DL
Proc Natl Acad Sci U S A; 1998 May; 95(10):5562-7. PubMed ID: 9576922
[TBL] [Abstract][Full Text] [Related]
9. RAPGEF2 mediates oligomeric Aβ-induced synaptic loss and cognitive dysfunction in the 3xTg-AD mouse model of Alzheimer's disease.
Jang YN; Jang H; Kim GH; Noh JE; Chang KA; Lee KJ
Neuropathol Appl Neurobiol; 2021 Aug; 47(5):625-639. PubMed ID: 33345400
[TBL] [Abstract][Full Text] [Related]
10. Over-expression of miR-34a induces rapid cognitive impairment and Alzheimer's disease-like pathology.
Sarkar S; Engler-Chiurazzi EB; Cavendish JZ; Povroznik JM; Russell AE; Quintana DD; Mathers PH; Simpkins JW
Brain Res; 2019 Oct; 1721():146327. PubMed ID: 31295467
[TBL] [Abstract][Full Text] [Related]
11. Tripchlorolide improves cognitive deficits by reducing amyloid β and upregulating synapse-related proteins in a transgenic model of Alzheimer's Disease.
Zeng Y; Zhang J; Zhu Y; Zhang J; Shen H; Lu J; Pan X; Lin N; Dai X; Zhou M; Chen X
J Neurochem; 2015 Apr; 133(1):38-52. PubMed ID: 25661995
[TBL] [Abstract][Full Text] [Related]
12. Cognitive Decline and Modulation of Alzheimer's Disease-Related Genes After Inhibition of MicroRNA-101 in Mouse Hippocampal Neurons.
Barbato C; Giacovazzo G; Albiero F; Scardigli R; Scopa C; Ciotti MT; Strimpakos G; Coccurello R; Ruberti F
Mol Neurobiol; 2020 Jul; 57(7):3183-3194. PubMed ID: 32504417
[TBL] [Abstract][Full Text] [Related]
13. RPS23RG1 reduces Aβ oligomer-induced synaptic and cognitive deficits.
Yan L; Chen Y; Li W; Huang X; Badie H; Jian F; Huang T; Zhao Y; Cohen SN; Li L; Zhang YW; Luo H; Tu S; Xu H
Sci Rep; 2016 Jan; 6():18668. PubMed ID: 26733416
[TBL] [Abstract][Full Text] [Related]
14. ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology.
Sakae N; Liu CC; Shinohara M; Frisch-Daiello J; Ma L; Yamazaki Y; Tachibana M; Younkin L; Kurti A; Carrasquillo MM; Zou F; Sevlever D; Bisceglio G; Gan M; Fol R; Knight P; Wang M; Han X; Fryer JD; Fitzgerald ML; Ohyagi Y; Younkin SG; Bu G; Kanekiyo T
J Neurosci; 2016 Mar; 36(13):3848-59. PubMed ID: 27030769
[TBL] [Abstract][Full Text] [Related]
15. p110δ PI3-Kinase Inhibition Perturbs APP and TNFα Trafficking, Reduces Plaque Burden, Dampens Neuroinflammation, and Prevents Cognitive Decline in an Alzheimer's Disease Mouse Model.
Martínez-Mármol R; Mohannak N; Qian L; Wang T; Gormal RS; Ruitenberg MJ; Vanhaesebroeck B; Coulson EJ; Meunier FA
J Neurosci; 2019 Oct; 39(40):7976-7991. PubMed ID: 31363064
[TBL] [Abstract][Full Text] [Related]
16. A novel missense variant in ACAA1 contributes to early-onset Alzheimer's disease, impairs lysosomal function, and facilitates amyloid-β pathology and cognitive decline.
Luo R; Fan Y; Yang J; Ye M; Zhang DF; Guo K; Li X; Bi R; Xu M; Yang LX; Li Y; Ran X; Jiang HY; Zhang C; Tan L; Sheng N; Yao YG
Signal Transduct Target Ther; 2021 Aug; 6(1):325. PubMed ID: 34465723
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Toxic Amyloid 42 Oligomers in Rat Primary Cerebral Cortex Cells and Human iPS-derived Neurons Treated with 10-Me-Aplog-1, a New PKC Activator.
Murakami K; Yoshimura M; Nakagawa S; Kume T; Kondo T; Inoue H; Irie K
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32053979
[TBL] [Abstract][Full Text] [Related]
18. The Role of Lysosomes in a Broad Disease-Modifying Approach Evaluated across Transgenic Mouse Models of Alzheimer's Disease and Parkinson's Disease and Models of Mild Cognitive Impairment.
Hwang J; Estick CM; Ikonne US; Butler D; Pait MC; Elliott LH; Ruiz S; Smith K; Rentschler KM; Mundell C; Almeida MF; Stumbling Bear N; Locklear JP; Abumohsen Y; Ivey CM; Farizatto KLG; Bahr BA
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31505809
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase C{alpha}, but not PKC{beta} or PKC{gamma}, regulates contractility and heart failure susceptibility: implications for ruboxistaurin as a novel therapeutic approach.
Liu Q; Chen X; Macdonnell SM; Kranias EG; Lorenz JN; Leitges M; Houser SR; Molkentin JD
Circ Res; 2009 Jul; 105(2):194-200. PubMed ID: 19556521
[TBL] [Abstract][Full Text] [Related]
20. Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease model.
Imamura T; Yanagihara YT; Ohyagi Y; Nakamura N; Iinuma KM; Yamasaki R; Asai H; Maeda M; Murakami K; Irie K; Kira JI
Neurobiol Dis; 2020 Apr; 137():104739. PubMed ID: 31927145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
